Onyx Biotec Stock Price Analysis and Quick Research Report. Is Onyx Biotec an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Onyx Biotec. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Onyx Biotec has a PE ratio of 18.6628609067955 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Onyx Biotec has ROA of 4.5636% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Onyx Biotec has a Current ratio of 1.3078.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Onyx Biotec has a ROE of 14.0742%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Onyx Biotec has a Debt to Equity ratio of 1.2372 which means that the company has low proportion of debt in its capital.

• Sales growth: Onyx Biotec has reported revenue growth of 36.1353% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Onyx Biotec for the current financial year is 15.5032298395499%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Onyx Biotec is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Onyx Biotec is Rs 2.7327. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Onyx Biotec in Ticker for free. Also, one can get the intrinsic value of Onyx Biotec by using Valuation Calculators, which are available with a Finology ONE subscription. 

Onyx Biotec FAQs

Q1. What is Onyx Biotec share price today?
Ans: The current share price of Onyx Biotec is Rs 51.

Q2. What is the market capitalisation of Onyx Biotec?
Ans: Onyx Biotec has a market capitalisation of Rs 92.47422 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Onyx Biotec?
Ans: The PE ratio of Onyx Biotec is 18.6628609067955 and the P/B ratio of Onyx Biotec is 1.70554871849751, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Onyx Biotec share?
Ans: The 52-week high share price of Onyx Biotec is Rs 97.45, and the 52-week low share price of Onyx Biotec is Rs 45.

Q5. Does Onyx Biotec pay dividends?
Ans: Currently, Onyx Biotec does not pay dividends. Dividend yield of Onyx Biotec is around 0%.

Q6. What are the face value and book value of Onyx Biotec shares?
Ans: The face value of Onyx Biotec shares is Rs 10, while the book value per share of Onyx Biotec is around Rs 29.9024. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Onyx Biotec?
Ans: Onyx Biotec has a total debt of Rs 30.7804 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Onyx Biotec?
Ans: The ROE of Onyx Biotec is 14.0742% and ROCE of Onyx Biotec is 12.0459%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Onyx Biotec a good buy for the long term?
Ans: The Onyx Biotec long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Onyx Biotec undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Onyx Biotec appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Onyx Biotec’s financials?
Ans: You can review Onyx Biotec’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.